All Type of News
Increasing interests towards ‘edoxaban’ due to the NOAC benefit enlargement
Along with the news about the benefit enlargement, the industry has paid attention to the domestic acceptance period of the fourth New Oral Anti-Coagulant(NOAC).
According to the industry concerned on the 29th, Daiic...
The pharmaceutical industry has kept a close watch on drug price of the Dong-A ST’s super antibacterial drug ‘Sivextro’As creation of a new global drug has been highly interested by the successful development of domestic pharmaceutical companies, the Dong-A ST’s new super antibacterial drug, ‘Si...
|
The Korea Bio Association established a presence at the U.S. high-tech biopharmaceutical support center
As a part of the U.S. economic mission, the Korea Bio Association announced on the 25th that it has signed a business agreement with the US Texas Healthcare & Bioscience Institute(THBI) on the last 18th of June and es...
Enlargement of price limit benefited pharmaceutical stocks, increasing 20% in a favorable condition
Since the 15th of this month, enlargement of price limit from 15% to 30% has benefited stock price of pharmaceutical companies.
Although an opinion was raised that the spread of MERS might stop the uptrend of pharmac...
Pharmaceutical companies grasping the situation for the adoption of the ‘Wage Peak System’
While the government has selected the pharmaceutical field as a leading business type that will adopt the Wage Peak System among private companies, a number of top pharmaceutical companies have been hesitated to decid...
The KRW 43 billion ‘Vytorin Tab’ market is noticed by 23 generic products
Domestic pharmaceutical companies have kept eyes on the hyperlipidemia treatment ‘Vytorin Tab’ market, which used to worth KRW 43 billion last year.
According to the Ministry of Food and Drug Safety, 12 pharmaceutica...
A private equity fund operator, ‘H&Q,’ takes over Ildong Pharmaceutical’s shares owned by Green Cross
H&Q Korea, a domestic private equity fund operator, will become the 2nd largest shareholder of Ildong Pharmaceutical as purchasing closely 25% of its shares owned by Green Cross, the former 2nd largest shareholder.
O...
The Korea Pharmaceutical Distribution Association resumes a fight against Hanmi Pharm
As the Korea Pharmaceutical Distribution Association(KPDA) was rejected by Hanmi Pharm over a suggestion to address their problem through communication and negotiation, it seems to decide a firm fight.
The Korea Phar...
The amendment for the prescription reusing has been tabled
An amendment for the prescription reusing has been tabled.
If a chronic disease patient is not able to be prescribed by temporary suspension of the hospital which has given treatment and prescriptions, the amendment ...
“Transforming medical devices to health care apparatus cannot be accepted”
A bill to exclude medical devices, such as electrocardiogram devices, pneumatometers and ultrasonic simulators, from the Medical Device Regulation Act by categorizing them into the ‘wellness product’ has been pushed. ...
